Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 900 of 984 entries
View as:

A Trial to Evaluate the Safety and Tolerability of Namilumab (MT203) in Patients With Mild to Moderate Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01317797 Org: User:
Start: 03/31/11 End: 08/31/13 Due: 08/31/14

Cognitive and Mood Assessment Data in Major Depressive Disorder Using Digital Wearable Technology

Phase: N/A Priority: Normal
NCT ID: NCT03067506 Org: User:
Start: 03/01/17 End: 07/03/17 Due: 07/03/18

A Study of TAK-103 in Adult With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05164666 Org: User:
Start: 01/05/22 End: 02/22/25 Due: 02/22/26

A Study of TAK-279 in Adults With or Without Liver Damage

Phase: N/A Priority: Normal
NCT ID: NCT05976321 Org: User:
Start: 09/22/23 End: 04/15/24 Due: 04/15/25

A Study to Evaluate the Effect of High-Fat Meal on TAK-788 Pharmacokinetics (PK) in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT04441255 Org: User:
Start: 07/01/20 End: 08/10/20 Due: 08/10/21

Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis

Phase: N/A Priority: Normal
NCT ID: NCT01478971 Org: User:
Start: 10/31/11 End: 02/28/13 Due: 02/28/14

Efficacy and Safety Study of Alogliptin and Insulin in the Treatment of Type 2 Diabetes.

Phase: N/A Priority: Normal
NCT ID: NCT00286429 Org: User:
Start: 02/28/06 End: 05/31/07 Due: 05/31/08

Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)

Phase: N/A Priority: Normal
NCT ID: NCT01101035 Org: User:
Start: 04/23/10 End: 07/18/17 Due: 07/18/18

A Study to Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil Alone

Phase: N/A Priority: Normal
NCT ID: NCT01456169 Org: User:
Start: 10/31/11 End: 01/31/13 Due: 01/31/14

A Study of TAK-227 in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05818956 Org: User:
Start: 05/25/23 End: 06/26/23 Due: 06/26/24

Safety, Tolerability, and Pharmacokinetics of TAK-438 in Healthy Western Male Subjects, Preliminary Food Effect Analysis, and an Ethnic Comparison With Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02141698 Org: User:
Start: 10/31/07 End: 02/29/08 Due: 02/28/09

An Efficacy and Safety of Flomoxef Versus Cefepime in the Treatment of Participants With Urinary Tract Infections

Phase: N/A Priority: Normal
NCT ID: NCT02302092 Org: User:
Start: 12/01/15 End: 12/15/16 Due: 12/15/17

Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01456195 Org: User:
Start: 11/30/11 End: 07/31/13 Due: 07/31/14

Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Monotherapy/Combination Therapy With α-GI"

Phase: N/A Priority: Normal
NCT ID: NCT01945216 Org: User:
Start: 07/08/10 End: 10/31/15 Due: 10/31/16

Efficacy and Safety of Azilsartan Medoxomil in African American Participants With Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00591253 Org: User:
Start: 10/31/07 End: 04/30/09 Due: 04/30/10

Drug Use Study of Febuxostat After Recent Changes in the Prescribing Information

Phase: N/A Priority: Normal
NCT ID: NCT04853160 Org: User:
Start: 08/15/20 End: 01/05/21 Due: 01/05/22

Healthy and Renal Impairment Study of Colcrys (Colchicine, USP)

Phase: N/A Priority: Normal
NCT ID: NCT01084278 Org: User:
Start: 05/31/10 End: 02/28/11 Due: 02/28/12

Pharmacokinetics and Pharmacodynamics of TAK-875 in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00949091 Org: User:
Start: 01/31/09 End: 07/31/09 Due: 07/31/10

Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children

Phase: N/A Priority: Normal
NCT ID: NCT02948829 Org: User:
Start: 04/03/17 End: 12/14/20 Due: 12/14/21

A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions

Phase: N/A Priority: Normal
NCT ID: NCT05816382 Org: User:
Start: 04/05/23 End: 02/28/28 Due: 02/28/29

A Continuation Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Phase: N/A Priority: Normal
NCT ID: NCT06948318 Org: User:
Start: 08/29/25 End: 07/29/29 Due: 07/29/30

Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis and Maintenance of Healed Erosive Esophagitis and Relief of Heartburn in Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT01642615 Org: User:
Start: 07/31/12 End: 11/30/14 Due: 11/30/15

Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac Disease

Phase: N/A Priority: Normal
NCT ID: NCT00521742 Org: User:
Start: 03/31/01 End: 01/31/03 Due: 01/31/04

Effect of Lapaquistat Acetate Combined With Fenofibrate on Blood Cholesterol Levels

Phase: N/A Priority: Normal
NCT ID: NCT00813527 Org: User:
Start: 02/28/06 End: 01/31/07 Due: 01/31/08

Pharmacokinetics, Safety, and Efficacy of Brigatinib Monotherapy in Pediatric and Young Adult Participants With ALK+ Anaplastic Large Cell Lymphoma, Inflammatory Myofibroblastic Tumors or Other Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04260009 Org: User:
Start: 09/01/20 End: 09/01/25 Due: 09/01/26